The role of PPAR-β/-δ in the regulation of glucose homeostasis has emerged with the findings that PPAR-β/-δ agonists reduce adiposity and improve glucose tolerance and insulin sensitivity in different mouse models of obesity [153]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.